Management by Size and Modality
| Modality | Size / Finding | Recommendation |
|---|---|---|
| CT (any incidental finding) | Any pituitary lesion | Dedicated pituitary MRI (3T preferred) for characterization; distinguish from normal variant |
| MRI — microadenoma (<10 mm) | <6 mm | No follow-up imaging; endocrinology referral only if clinical concern for hormonal excess |
| MRI — microadenoma | 6–9 mm | Repeat pituitary MRI in 12 months; if stable → discontinue; endocrinology referral |
| MRI — macroadenoma (≥10 mm) | 10–29 mm, no chiasm contact | Endocrinology referral; repeat MRI in 6 months; ophthalmology if any visual symptoms |
| MRI — macroadenoma | ≥30 mm or chiasm contact/compression | Urgent endocrinology + neurosurgery referral; formal visual field testing |
| FDG-PET (incidental uptake) | Any focal pituitary uptake | Dedicated pituitary MRI; endocrinology referral |
Incidental CT findings of a pituitary lesion should always prompt dedicated pituitary MRI — CT has poor soft-tissue resolution for the sella and cannot characterize adenoma morphology or chiasm involvement reliably.
Biochemical Screening for Macroadenomas
All macroadenomas (≥10 mm) should have biochemical evaluation regardless of symptoms:
| Hormone Axis | Test | What to Exclude |
|---|---|---|
| Prolactin | Serum prolactin | Prolactinoma — medically treated; do not operate first |
| Cortisol/ACTH | 24-hr urine free cortisol or overnight DST | Cushing's disease |
| GH/IGF-1 | Serum IGF-1 | Acromegaly |
| Thyroid | TSH, free T4 | TSH-secreting adenoma |
| Gonadal | LH, FSH, testosterone (men) or estradiol (women) | Gonadotroph adenoma, hypogonadism |
Prolactinoma is the most common functioning pituitary adenoma — rule it out first, because prolactinomas are treated medically with dopamine agonists (cabergoline), not surgery. A very high prolactin level (>200 ng/mL) is almost diagnostic. Levels 25–200 ng/mL can also be seen with "stalk effect" from any large non-functioning mass compressing the portal system.
Why This Matters
Pituitary incidentalomas ("incidentalomas") are found in approximately 10% of brain MRIs performed for other indications. The vast majority are small nonfunctioning microadenomas that require limited workup. The critical findings to recognize are chiasm contact or compression (optic pathway at risk, requiring urgent surgical evaluation) and any clinical or biochemical evidence of hormonal excess. A macroadenoma discovered to be a prolactinoma will be treated medically — this changes management entirely.
Reference
Hoang JK, Hoffman AR, González RG, et al. Management of Incidental Pituitary Findings on CT, MRI, and ¹⁸F-Fluorodeoxyglucose PET: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol. 2018;15(7):966–972.